Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Director acquired 34,208 shares (grant or award)
  5. 4 Open-market sale CEO sold 5,483 shares at $18.18 ($99,691)
  6. 4 Open-market sale President sold 2,865 shares at $18.18 ($52,091)
  7. 4 Open-market sale EVP,General Counsel, Secretary sold 894 shares at $18.18 ($16,255)
  8. 4 Open-market sale EVP, COO, Head of Commercial sold 552 shares at $18.18 ($10,036)
  9. 4 Open-market sale Principal Accounting Officer sold 1,025 shares at $27.05 ($27,726)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Principal Accounting Officer sold 359 shares at $23.80 ($8,544)
  17. 4 Open-market sale EVP, COO, Head of Commercial sold 472 shares at $23.80 ($11,234)
  18. 4 Open-market sale Chief Financial Officer sold 553 shares at $23.80 ($13,161)
  19. 4 Open-market sale EVP & General Counsel sold 782 shares at $23.80 ($18,612)
  20. 4 Open-market sale President sold 1,501 shares at $23.80 ($35,724)

Page 9 of 35 · 686 filings